Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
11/2012
11/28/2012CN202555012U Analginum intermediate recovery device
11/28/2012CN102796045A Pyrazoline derivatives, and preparation method and application thereof
11/28/2012CN101679282B Method for the production of N-substituted (3-dihalomethyl-1-methyl-pyrazole-4-yl) carboxamides
11/27/2012US8318796 Heterocyclic compounds and thrombopoietin receptor activators
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012CA2569592C Heterocyclic carboxamides with microbiocidal activity
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012US20120295938 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/22/2012US20120295874 Coferons and methods of making and using them
11/22/2012CA2836311A1 Amine derivatives as potassium channel blockers
11/21/2012EP2523939A1 Methods for the preparation of indazole-3-carboxyclic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt
11/21/2012CN1474803B Novel amide derivatives and medicinal use thereof
11/21/2012CN102791695A Cyclopentyl- and cycloheptylpyrazoles as FXR modulators
11/21/2012CN102791694A Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
11/21/2012CN102791693A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102786473A 1-vinyl pyrazole compound and its application
11/21/2012CN102786394A Substituent bis-aryl methylene naphthenic base derivative as well as preparation method and application thereof
11/21/2012CN102127020B Refining method of Edaravone compound
11/21/2012CN101970413B Process for the preparation of fipronil and analogues thereof
11/21/2012CN101955461B Hsp90 inhibitor Xbj-B11 and preparation method and application thereof
11/21/2012CN101906053B 酰胺衍生物 Amide derivatives
11/21/2012CN101827825B Crystalline chemotherapeutic
11/21/2012CN101792419B Synthetic method of compound blocked polyisocyanates by using multiple sealants to compound and block terminal groups
11/20/2012US8314246 Catalytic reactions involving alkenes
11/20/2012US8314099 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
11/20/2012CA2587528C Method for preparing n-phenylpyrazole-1-carboxamides
11/20/2012CA2529878C Pyrazole derivative, drug composition containing the same and production intermediate therefor
11/15/2012WO2012154249A1 Substituted aminobutyric derivatives as neprilysin inhibitors
11/15/2012WO2012153341A1 A process for the preparation of iloperidone and pharmaceutically acceptable salts thereof
11/15/2012WO2012152763A1 Substituted indazole derivatives active as kinase inhibitors
11/15/2012WO2012151958A1 Low-toxic 3-pyrazole carboxylic acid amides, preparation methods and uses thereof in manufacture of medicines as cb1 receptor inhibitors
11/15/2012US20120289707 Process for the preparation of amides
11/15/2012US20120289506 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
11/15/2012US20120289403 Fluorinated Oxa or Thia Heteroarylalkylsulfide Derivatives for Combating Invertebrate Pests
11/15/2012CA2835610A1 Proteostasis regulators
11/15/2012CA2835478A1 Substituted indazole derivatives active as kinase inhibitors
11/14/2012EP2522670A1 Heterocyclic CRF receptor antagonists
11/14/2012CN102781920A Process for synthesis of fipronil
11/14/2012CN102775350A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors
11/14/2012CN101778846B 1,2-diamido-ethylene derivatives as orexin antagonists
11/13/2012US8309592 Fungicidal N-cycloalkyl-benzyl-thiocarboxamides or N-cycloalkyl-benzyl-N′-substituted-amidine derivatives
11/13/2012US8309543 Compositions useful as inhibitors of voltage-gated sodium channels
11/13/2012CA2454306C Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
11/08/2012US20120283305 Cysteine protease inhibitors
11/08/2012US20120283287 Certain chemical entities, compositions, and methods
11/07/2012EP2520638A1 Anti-wear agent, additive composition for lubricant, and lubricant composition
11/07/2012EP2520568A1 Spirocyclic nitriles as inhibitors of protease
11/07/2012EP2520561A1 IRE-1A Inhibitors
11/07/2012EP2519506A1 Hepatitis c virus inhibitors
11/07/2012CN102766097A Edaravone A-type crystal and preparation method thereof
11/07/2012CN102766096A Method for preparing 3-difluoromethyl-1-methyl-1-hydrogen-pyrazole-4-carboxylic acid and ester thereof
11/07/2012CN102766095A Preparation method of electron-deficient group-containing multi-substituted pyrazole derivative
11/07/2012CN101583622B Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
11/07/2012CN101528707B 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
11/06/2012US8304559 Method for the synthesis of 5-amino-1-phenyl-3-cyano-4-trifluoromethyl sulfinyl
11/06/2012US8304553 Method of forming oseltamivir and derivatives thereof
11/06/2012US8304445 7-pyrazolyl tetracycline compounds and methods of use thereof
11/06/2012US8304444 Pyrazole carboxylic acid amides useful as microbiocides
11/06/2012US8304443 Indazole derivatives
11/06/2012US8304436 Pyrazolone derivatives as PDE4 inhibitors
11/01/2012US20120277258 Chemical Compounds
11/01/2012US20120277190 Prodrugs of compounds that inhibit trpv1 receptor
11/01/2012US20120276006 Contrast agents for myocardial perfusion imaging
10/2012
10/31/2012EP2518054A1 Amide compound
10/31/2012EP2518051A1 Adamantanamine derivative
10/31/2012CN102762540A Pyrazole microbiocides
10/31/2012CN102762531A Adamantanamine derivative
10/31/2012CN102757386A Peptide derivative and pharmaceutical composition and application thereof
10/31/2012CN101395138B Sigma receptor inhibitors
10/30/2012US8299260 Process for preparing aryl-substituted pyrazoles
10/30/2012US8299243 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
10/30/2012US8299112 Estrogen receptor modulators and uses thereof
10/30/2012US8299111 Compounds which modulate the CB2 receptor
10/30/2012US8299096 Method for treating pulmonary diseases using rho kinase inhibitor compounds
10/30/2012US8299072 Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof
10/30/2012US8299070 Indole compounds and pharmaceutical use thereof
10/30/2012US8299063 Amido-thiophene compounds and their use
10/30/2012US8299057 Substituted indazole derivatives active as kinase inhibitors
10/30/2012US8299048 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
10/30/2012US8299047 2-alkyl-cycloalk(en)yl-carboxamides
10/30/2012CA2556078C Carboxamides
10/30/2012CA2548156C Amine derivatives
10/26/2012WO2012145361A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/25/2012US20120270918 Pyrazole Derivatives, Preparation Thereof, and Therapeutic Use Thereof
10/25/2012US20120270902 N-substituted benzene sulfonamides
10/25/2012US20120270865 Heterocyclic compound
10/24/2012EP2514745A1 GPR120 receptor agonists and uses thereof
10/24/2012EP2513063A1 Method for producing 1-alkyl-/1-aryl-5-pyrazole-carboxylic acid derivatives
10/24/2012EP2512466A1 Prodrugs of inhibitors of plasma kallikrein
10/24/2012CN102753531A Method for producing 1-alkyl-/1-aryl-5-pyrazole-carboxylic acid derivatives
10/24/2012CN102753527A Cyclohexyl amide derivatives as crf receptor antagonists
10/24/2012CN102753155A 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
10/24/2012CN102753154A 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts
10/24/2012CN102746234A Process for the sulfinylation of a pyrazole derivative
10/24/2012CN102746233A Process for the sulfinylation of a pyrazole derivative
10/24/2012CN102746232A Preparation method of celecoxib impurity
10/24/2012CN102746231A Celecoxib preparation process
10/24/2012CN101668524B Pyrazole derivatives as 11-beta-hsd1 inhibitors
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 256